-
April 14, 2022 Why Investors Should Care About MindMed’s LSD Trial for AnxietyMindMed will present preliminary results from a Phase 2a study treating Generalized Anxiety Disorder with...
-
April 8, 2022 Psychedelic Business Spotlight – April 8This week in psychedelic business news: Field Trip Health secures a patent; Core One Labs...
-
March 30, 2022 5 Most Important Psychedelic Clinical Trials in 2022Here's why we think MAPS’ second Phase 3 MDMA trial is the most important psychedelic...
-
March 14, 2022 5 Mind-Bending Psychedelic Movies to Stream Right NowSkip the drugs, and take a trip on the screen instead.
-
March 10, 2022 Psychedelic Researchers Doubt Microdosing in New York TimesAfter a disappointing microdosing study, Dr. Michiel van Elk says the trend is "just not...
-
March 7, 2022 Is Wall Street the Next Stop for Psychedelics? Investing in the Psychedelic Medicine SectorElemental Advisors Inc. CEO Tim Collins paints a picture of the past, present, and future...
-
March 5, 2022 Is There a Difference Between Tripping on LSD and Psilocybin?A double-blinded, randomized, and placebo-controlled study compares the subjective and autonomic effects of both psychedelics.
-
February 24, 2022 LSD Microdosing Study Finds ‘No Residual Effects’ on Mood or CognitionAnother study concludes with results challenging the increasingly popular narrative that microdosing psychedelics improves mood...
-
February 4, 2022 Psychedelic Business Spotlight – February 4Levitee Labs Announces Interim CEO and Board of Directors ShuffleThis week in psychedelic business news,...
-
January 24, 2022 How to Prepare for Your First Psychedelic Trip in 5 Easy StepsPsilocybin and LSD are becoming more popular and more accessible, but before your first psychedelic...
